How much funding has Acclaro raised?

Acclaro has raised $23.0M in total funding, most recently a Series B round.

Who are Acclaro's investors?

Acclaro's investors include Accelmed Partners, 3E Bioventures Capital.

Where is Acclaro headquartered?

Acclaro is headquartered in United States.

What industry is Acclaro in?

Acclaro operates in Healthcare.

Acclaro

FA International – Cutting Edge Fiber Laser Technology

United States · $23.0M raised

Healthcare

Business Model: B2B
Website: fa-in.com
Total Funding: $23.0M

Last Round: $23.0M Series BMay 2025
Rounds: 1

About

FA International (operating at fa-in.com) is a product design and manufacturing company specializing in mid-infrared fiber laser systems for the medical aesthetics and industrial laser markets, offering OEM turn-key design-to-manufacturing solutions for medical device partners. Led by President Shlomo Assa, a 30-year industry veteran and former global CTO of Candela — one of the world's largest laser medical aesthetic companies — FA International provides full product lifecycle services including material management, distribution, and after-market support. The company serves medical device partners and industrial customers across the US, Europe, and APAC regions.

Summary

Acclaro is a Healthcare company based in United States. It has raised $23.0M in total across 1 round, most recently a $23.0M Series B round in May 2025. Investors include Accelmed Partners and 3E Bioventures Capital.